Skip to main content
SpringerLink
Log in

La strategia nell’uso del mitotane

  • SURRENE
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Bibliografia

  1. Fassnacht M, Dekkers O, Else T et al. (2018) European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179(4):G1–46

    Article  CAS  PubMed  Google Scholar 

  2. Terzolo M, Angeli A, Fassnacht M et al. (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356(23):2372–2380

    Article  CAS  PubMed  Google Scholar 

  3. Berruti A, Grisanti S, Pulzer A et al. (2017) Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma. J Clin Endocrinol Metab 102(4):1358–1365

    Article  PubMed  Google Scholar 

  4. Calabrese A, Basile V, Puglisi S et al. (2019) Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. Eur J Endocrinol 180(6):389–398

    Article  Google Scholar 

  5. Tang Y, Liu Z, Zou Z et al. (2018) Benefits of adjuvant mitotane after resection of adrenocortical carcinoma: a systematic review and meta-analysis. BioMed Res Int 2018:1–8

    Google Scholar 

  6. Megerle F, Herrmann W, Schloetelburg W et al. (2018) Mitotane monotherapy in patients with advanced adrenocortical carcinoma. J Clin Endocrinol Metab 103(4):1686–1695

    Article  PubMed  Google Scholar 

  7. Reidy-Lagunes DL, Lung B, Untch BR et al. (2017) Complete responses to mitotane in metastatic adrenocortical carcinoma—a new look at an old drug. The Oncologist 22(9):1102–1106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Vezzosi D, Do Cao C, Hescot S et al. (2018) Time until partial response in metastatic adrenocortical carcinoma long-term survivors. Horm Cancer 9(1):62–69

    Article  CAS  PubMed  Google Scholar 

  9. Reimondo G, Puglisi S, Zaggia B et al.(2017) Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma. Eur J Endocrinol 177(4):361–367

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medicina Interna, Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi di Torino, AOU San Luigi Gonzaga, Orbassano, Italia

    Anna Calabrese, Soraya Puglisi, Vittoria Basile, Anna Pia & Massimo Terzolo

Authors
  1. Anna Calabrese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soraya Puglisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vittoria Basile
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Pia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Massimo Terzolo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Soraya Puglisi.

Ethics declarations

Conflitti di interesse

Le autrici Anna Calabrese, Vittoria Basile e Anna Pia dichiarano di non avere conflitti di interesse; Soraya Puglisi ha percepito un grant for scientific writing da HRA Pharma; Massimo Terzolo ha percepito un advisory board honoraria da HRA Pharma e un research grant da HRA Pharma.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studio sugli animali

Questo articolo non ha comportato studi sugli animali.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calabrese, A., Puglisi, S., Basile, V. et al. La strategia nell’uso del mitotane. L'Endocrinologo 21 (Suppl 1), 53–55 (2020). https://doi.org/10.1007/s40619-020-00712-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-020-00712-4

Search

Navigation